DoubleLine ETF Adviser’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
DoubleLine ETF Adviser's MRNA Position: Q3 2026 in Review
DoubleLine ETF Adviser sold out of Moderna (MRNA) in Q3 2026, closing a stake of 3,760 shares — an estimated $263K sold.
DoubleLine ETF Adviser first reported a position in MRNA in Q1 2026 and held it in 2 quarters. The position peaked at $263K in Q2 2026. 1,033 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- DoubleLine ETF Adviser reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
- DoubleLine ETF Adviser sold 3,760 Moderna shares in Q3 2026, an estimated $263K.
- DoubleLine ETF Adviser first reported a position in Moderna in Q1 2026 and held it in 2 quarters.
- DoubleLine ETF Adviser's Moderna position peaked at $263K in Q2 2026.
- 1,033 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on DoubleLine ETF Adviser's 13F filing for Q3 2026, filed 13 Nov 2026.